e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Therapy of thoracic tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Timing of radiotherapy and possible survival benefit in limited disease SCLC patients
K. Zarogoulidis, N. Secen, E. Boutsikou, A. Milovancev, E. Eleutheriadou, D. Bursac, V. Zarogoulidou, D. Skrbic, H. Lithoxopoulou, T. Kontakiotis (Sremska, Kamenica, Serbia And Montenegro; G. Papanikolaou Hospital, Greece)
Source:
Annual Congress 2008 - Therapy of thoracic tumours
Session:
Therapy of thoracic tumours
Session type:
E-Communication Session
Number:
4311
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Zarogoulidis, N. Secen, E. Boutsikou, A. Milovancev, E. Eleutheriadou, D. Bursac, V. Zarogoulidou, D. Skrbic, H. Lithoxopoulou, T. Kontakiotis (Sremska, Kamenica, Serbia And Montenegro; G. Papanikolaou Hospital, Greece). Timing of radiotherapy and possible survival benefit in limited disease SCLC patients. Eur Respir J 2008; 32: Suppl. 52, 4311
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
Lung function assessment in octogenarians with lung cancer diagnosis
NSCLC/SCLC diagnosis and staging of thoracic tumours
Related content which might interest you:
Symptomatic benefit of short regimen of palliative radiotherapy for elderly patients with locally advanced non small cell lung cancer
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010
Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT).
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
Impact of radiotherapy on survival rates in chemotherapy treated non small cell lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Impact of radiotherapy on survival rates in chemotherapy treated small cell lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Bevacizumab shows survival benefit for non-small lung cancer patients who received subsequent pemetrexed treatment but not had a therapeutic effect in clinical practice
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Is there any survival benefit of surgery after neoadjuvant chemoradiotherapy and persisting pn2/3 in stage III NSCLC?
Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer
Year: 2009
Improved overall survival after late recurrence of lung cancer following the introduction of CT-based follow-up for patients treated with curative intent
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018
Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients?
Source: Eur Respir J 2002; 19: 464-468
Year: 2002
Long-term survival of the patients with advanced non small cell lung carcinomas after induction chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 78s
Year: 2005
Early concurrent chemoradiotherapy for limited small cell lung cancer (LSCLC). Analysis of toxicity and survival of 30 consecutive patients
Source: Eur Respir J 2002; 20: Suppl. 38, 464s
Year: 2002
Assessment of lung cancer related symptoms and chemotherapy related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 752s
Year: 2006
Impact of neoadjuvant therapy on tumor resectability and survival of patients with locally advanced non-small cell lung cancer
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011
Impact of neoadjuvant therapies on surgical indications and early postoperative outcome
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005
Definitive radiation therapy for elderly patients with stage III NSCLC not candidates for combined chemoradiation
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Outcome after pneumonectomy in non small cell lung cancer patients receiving a neoadjuvant therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 478s
Year: 2004
Influence of the limited lung function to the outcome of the surgical treatment in patients with NSCLC
Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients
Year: 2003
Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011
Clinical factors of long-term survival in patients with advanced lung cancer
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
Locally advanced disease – indications and results of extended resections
Source: Annual Congress 2005 - Borderline indications for surgical treatment of non-small cell lung cancer
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept